Cargando…

Advances in the treatment of rheumatoid arthritis

The intense pursuit of novel therapies in rheumatoid arthritis has provided physicians with an assorted set of biologic drugs to treat patients with moderate to severe disease activity. Nine different biologic therapies are currently available: seven inhibitors of pro-inflammatory cytokines (five ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vivar, Nancy, Van Vollenhoven, Ronald F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017904/ https://www.ncbi.nlm.nih.gov/pubmed/24860653 http://dx.doi.org/10.12703/P6-31

Ejemplares similares

Infliximab Versus Conventional Combination Treatment and Seven‐Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial
por: Eriksson, Jonas K., et al.
Publicado: (2016)

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
por: Nagy, György, et al.
Publicado: (2015)

Sex differences in rheumatoid arthritis: more than meets the eye...
por: van Vollenhoven, Ronald F
Publicado: (2009)

Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study
por: Lesuis, Nienke, et al.
Publicado: (2012)

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
por: Genovese, Mark C., et al.
Publicado: (2016)

Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial
por: Levitsky, Adrian, et al.
Publicado: (2015)

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2016)

Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis
por: Mullazehi, Mohammed, et al.
Publicado: (2012)

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
por: Kerschbaumer, Andreas, et al.
Publicado: (2020)

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
por: van Vollenhoven, Ronald F, et al.
Publicado: (2016)

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis
por: de Jong, Tamarah D., et al.
Publicado: (2019)

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial
por: Levitsky, Adrian, et al.
Publicado: (2017)

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
por: Burmester, Gerd R, et al.
Publicado: (2016)

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
por: Fleischmann, Roy M, et al.
Publicado: (2016)

Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort
por: Lourdudoss, Cecilia, et al.
Publicado: (2018)

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
por: Pieper, Jennifer, et al.
Publicado: (2013)

Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
por: Smolen, Josef S, et al.
Publicado: (2018)

Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry”
por: van Vollenhoven, Ronald F, et al.
Publicado: (2023)

Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
por: Mueller, Anna-Lena, et al.
Publicado: (2021)

Interferon-β for treatment of rheumatoid arthritis?
por: van Holten, Judith, et al.
Publicado: (2002)

Use of Herbal Medications for Treatment of Osteoarthritis and Rheumatoid Arthritis
por: Lindler, Breanna N., et al.
Publicado: (2020)

Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes
por: Frazzei, Giulia, et al.
Publicado: (2022)

The Treatment of Rheumatoid Arthritis
Publicado: (1929)

Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study
por: Lourdudoss, Cecilia, et al.
Publicado: (2017)

Clinically relevant advances in rheumatoid arthritis therapy
por: Müller-Ladner, Ulf, et al.
Publicado: (2009)

Rheumatoid Arthritis Revisited – Advanced Imaging Review
por: Vyas, Surabhi, et al.
Publicado: (2016)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)

Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009)

Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011)

Antibiotics for the treatment of rheumatoid arthritis
por: Ogrendik, Mesut
Publicado: (2013)

Rheumatoid Arthritis and Its Treatment
Publicado: (1932)

The Treatment of Rheumatoid Arthritis and Sciatica
Publicado: (1933)

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
por: Smolen, Josef S, et al.
Publicado: (2016)

Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study
por: Kastbom, Alf, et al.
Publicado: (2012)

Treatment of juvenile rheumatoid arthritis
por: Kim, Kwang Nam
Publicado: (2010)

Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis
por: Xu, Yuyi, et al.
Publicado: (2023)

Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor–methotrexate combination therapy versus triple therapy in rheumatoid arthritis
por: Fleischmann, Roy, et al.
Publicado: (2017)

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ko1517k4c389nv7gjdgrlgakcv